Td Private Client Wealth LLC Recursion Pharmaceuticals, Inc. Transaction History
Td Private Client Wealth LLC
- $4.07 Trillion
- Q2 2025
A detailed history of Td Private Client Wealth LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 126 shares of RXRX stock, worth $817. This represents 0.0% of its overall portfolio holdings.
Number of Shares
126Holding current value
$817% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
358Shares Held
285MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$226 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$210 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$158 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$112 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$95.2 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.17B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...